Home
TOP INDUSTRY NEWS
-
Catalent To Sell Somerset NJ Oral Solids Facility to CDMO Ardena
-
Lundbeck To Acquire Longboard Pharmaceuticals for $2.6 Bn
-
Mfg News: Chiesi, GSK, Sanofi & More
-
M&A News: Merck & Co, Sanofi & More
-
Partnering News: Astellas, Merck & Co., Teva & More
-
GSK Reaches $2.2-Bn Settlement Agreement in Zantac Product Liability Litigation
Features
-
Mitigating Supplier Risk for Steady-State Operations
Continual monitoring and evaluation of risk once working with suppliers is critical. An upcoming DCAT webinar will provide a customer–supplier view of the key performance indicators. key risk indicators, challenges, and scenarios to take into consideration to mitigate risk.
-
Solid-Dosage CDMO Sector: Is a Shakeup in the Making?
Novo Holdings’ pending $16.5-billion acquisition of Catalent to acquire sterile manufacturing capacity to support its Type 2 and obesity drugs is a major move in the CDMO drug-product space, but what are the implications for other assets in the deal, notably solid dosage products?
-
SPONSORED CONTENT
Overcoming Barriers To Patient Adherence With A Novel Dosage Form
-
SPONSORED CONTENT
OLON GROUP ANNOUNCES THE ACQUISITION OF GTP BIOWAYS GROUP
-
SPONSORED CONTENT
Global Scenario: Opportunities and Challenges in Peptides
DCAT MEMBER COMPANY COMMUNITY
-
Women Leaders in Pharma Interview: Catalina Vargas, Senior Vice President and Global Supply Chain Lead, Bristol Myers Squibb
The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Catalina Vargas, Senior Vice President and Global Supply Chain Lead, Bristol Myers Squibb. Read…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…
-
Unwind and Network With Us at DCAT After The Show: Milan
Are you gearing up to attend the show in Milan? Join us on Wednesday, October 9th, for an unforgettable and highly anticipated annual networking event, DCAT After the Show! Regarded…
-
Women Leaders in Pharma Interview: Ilka Noack, Director of Quality Assurance and Regulatory Affairs, ChemCon GmbH
The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Ilka Noack, Director of Quality Assurance and Regulatory Affairs at ChemCon GmbH. Read her…
